Nephron Sparing Surgery in Renal Allograft in Recipients with de novo Renal Cell Carcinoma: Two Case Reports and Review of the Literature

Mandy Hubatsch; Robert Peters; Andreas Maxeiner; Nasrin El-Bandar; Sarah Weinberger; Frank Friedersdorff

doi:10.1159/000509292

Nephron Sparing Surgery in Renal Allograft in Recipients with de novo Renal Cell Carcinoma: Two Case Reports and Review of the Literature

Urol Int. 2020;104(11-12):997-999. doi: 10.1159/000509292. Epub 2020 Sep 23.

Authors

Mandy Hubatsch¹, Robert Peters¹, Andreas Maxeiner¹, Nasrin El-Bandar¹, Sarah Weinberger¹, Frank Friedersdorff²

Affiliations

¹ Department of Urology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
² Department of Urology, Charité - Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany, Frank.Friedersdorff@charite.de.

PMID: 32966984
DOI: 10.1159/000509292

Abstract

We report 2 cases of de novo renal cell carcinoma (RCC) in renal grafts after transplantation. Both patients underwent nephron sparing surgery (NSS) 211 and 167 months after transplantation, revealing papillary RCC with a tumour size >4 cm (pT1a). Within a follow-up of 25 and 32 months after NSS, a stable renal function without indication for dialysis was present. No recurrence of RCC in both cases was reported within the yearly routine examinations. NSS in kidney allografts is a safe procedure with preservation of renal function.

Keywords: Kidney transplantation; Nephron sparing surgery; Posttransplant malignancy; Renal cell carcinoma.

Publication types

Case Reports
Review

MeSH terms

Adult
Carcinoma, Renal Cell / surgery*
Humans
Kidney Neoplasms / surgery*
Kidney Transplantation*
Male
Middle Aged
Postoperative Complications / surgery*